Moran Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-192,436
Closed -$15.2M 490
2025
Q4
$15.2M Sell
192,436
-3,583
-2% -$281K 0.47% 64
2025
Q3
$15.7M Buy
196,019
+28,454
+17% +$2.43M 0.47% 65
2025
Q2
$15.2M Buy
167,565
+160,039
+2,126% +$14.6M 0.47% 61
2025
Q1
$705K Sell
7,526
-113
-1% -$10.1K 0.02% 334
2024
Q4
$694K Sell
7,639
-99
-1% -$9.45K 0.02% 334
2024
Q3
$803K Buy
7,738
+2,684
+53% +$274K 0.02% 314
2024
Q2
$490K Buy
5,054
+1,616
+47% +$149K 0.02% 342
2024
Q1
$310K Buy
+3,438
New +$291K 0.01% 377
2023
Q3
Sell
-279,515
Closed -$21.5M 375
2023
Q2
$21.5M Buy
279,515
+16,644
+6% +$1.29M 0.81% 29
2023
Q1
$19.8M Buy
262,871
+137,072
+109% +$10.2M 0.75% 37
2022
Q4
$9.91M Buy
+125,799
New +$9.43M 0.38% 86

Other funds holding CL

Moran Wealth Management's CL Position: Q1 2026 in Review

Moran Wealth Management sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 192,436 shares — an estimated $15.2M sold.

Moran Wealth Management first reported a position in CL in Q4 2022 and held it in 11 quarters. The position peaked at $21.5M in Q2 2023. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Moran Wealth Management reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Moran Wealth Management sold 192,436 Colgate-Palmolive shares in Q1 2026, an estimated $15.2M.
  • Moran Wealth Management first reported a position in Colgate-Palmolive in Q4 2022 and held it in 11 quarters.
  • Moran Wealth Management's Colgate-Palmolive position peaked at $21.5M in Q2 2023.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Moran Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.